Lesley Reeve

425 total citations
13 papers, 317 citations indexed

About

Lesley Reeve is a scholar working on Cancer Research, Small Animals and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Lesley Reeve has authored 13 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 3 papers in Small Animals and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Lesley Reeve's work include Carcinogens and Genotoxicity Assessment (6 papers), Animal testing and alternatives (3 papers) and Biomedical Ethics and Regulation (2 papers). Lesley Reeve is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Animal testing and alternatives (3 papers) and Biomedical Ethics and Regulation (2 papers). Lesley Reeve collaborates with scholars based in United Kingdom, United States and Netherlands. Lesley Reeve's co-authors include D. Gatehouse, Philippe Vanparys, David Kirkland, Paul Baldrick, Wanda Fields, Betsy Bombick, Kathy Fowler, Brian M. Keyser, Robert Leverette and M. Hollings and has published in prestigious journals such as British Journal of Clinical Pharmacology, Mutation research. Fundamental and molecular mechanisms of mutagenesis and Toxicology in Vitro.

In The Last Decade

Lesley Reeve

13 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Reeve United Kingdom 8 157 93 70 64 46 13 317
Darren Kidd United Kingdom 6 109 0.7× 121 1.3× 48 0.7× 85 1.3× 100 2.2× 9 330
Julia Kenny United Kingdom 10 131 0.8× 101 1.1× 42 0.6× 99 1.5× 71 1.5× 14 378
Carol Beevers United States 12 220 1.4× 121 1.3× 102 1.5× 110 1.7× 44 1.0× 22 402
Shambhu Roy United States 13 114 0.7× 70 0.8× 36 0.5× 118 1.8× 33 0.7× 27 332
Camille Géniès France 14 64 0.4× 128 1.4× 60 0.9× 56 0.9× 49 1.1× 26 436
Albrecht Poth Germany 11 188 1.2× 158 1.7× 64 0.9× 165 2.6× 81 1.8× 21 439
Özge Cemiloğlu Ülker Türkiye 11 49 0.3× 101 1.1× 83 1.2× 43 0.7× 20 0.4× 24 335
Joanna Klapacz United States 11 86 0.5× 81 0.9× 49 0.7× 274 4.3× 30 0.7× 19 473
Shinobu Wakuri Japan 12 98 0.6× 84 0.9× 42 0.6× 169 2.6× 100 2.2× 15 504
Jian‐Dong Duan United States 11 148 0.9× 64 0.7× 68 1.0× 117 1.8× 23 0.5× 23 319

Countries citing papers authored by Lesley Reeve

Since Specialization
Citations

This map shows the geographic impact of Lesley Reeve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Reeve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Reeve more than expected).

Fields of papers citing papers by Lesley Reeve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Reeve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Reeve. The network helps show where Lesley Reeve may publish in the future.

Co-authorship network of co-authors of Lesley Reeve

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Reeve. A scholar is included among the top collaborators of Lesley Reeve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Reeve. Lesley Reeve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Heras, Begoña de las, Lesley Reeve, Stephen Flach, et al.. (2021). Healthy volunteers in first‐in‐human oncology drug development for small molecules. British Journal of Clinical Pharmacology. 88(4). 1773–1784. 9 indexed citations
2.
Reeve, Lesley, Paul Baldrick, Andrew J. Newell, & Scott R. Templeton. (2019). Use of “Big Data” to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products. Therapeutic Innovation & Regulatory Science. 54(4). 764–769. 1 indexed citations
3.
Keyser, Brian M., et al.. (2019). Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system. Toxicology Reports. 6. 1281–1288. 13 indexed citations
4.
Fowler, Kathy, et al.. (2018). Development, qualification, validation and application of the Ames test using a VITROCELL® VC10® smoke exposure system. Toxicology Reports. 5. 542–551. 17 indexed citations
5.
Keyser, Brian M., Robert Leverette, Kathy Fowler, et al.. (2018). Development of a quantitative method for assessment of dose in in vitro evaluations using a VITROCELL® VC10® smoke exposure system. Toxicology in Vitro. 56. 19–29. 9 indexed citations
6.
7.
Reeve, Lesley & Paul Baldrick. (2017). Biocompatibility assessments for medical devices – evolving regulatory considerations. Expert Review of Medical Devices. 14(2). 161–167. 42 indexed citations
8.
Baldrick, Paul & Lesley Reeve. (2015). Risk Management Plans in the European Union: Nonclinical Aspects. Therapeutic Innovation & Regulatory Science. 50(1). 101–105. 2 indexed citations
9.
Kirkland, David, Lesley Reeve, D. Gatehouse, & Philippe Vanparys. (2011). A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 721(1). 27–73. 176 indexed citations
10.
Reeve, Lesley, et al.. (2011). A battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy. Journal of Applied Toxicology. 32(8). 608–616. 5 indexed citations
11.
Reeve, Lesley. (2009). Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals. Regulatory Toxicology and Pharmacology. 55(2). 181–187. 2 indexed citations
12.
Baldrick, Paul & Lesley Reeve. (2007). Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the CD–1 Mouse. Toxicologic Pathology. 35(4). 562–575. 22 indexed citations
13.
Clements, Julie, et al.. (1997). P XIX.2 The mouse lymphoma TK assay (MLA): experiences with continuous (24 hour) treatment incubation. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 379(1). S194–S194. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darren Kidd Breakdown of academic impact, for papers by Julia Kenny Breakdown of academic impact, for papers by Carol Beevers Breakdown of academic impact, for papers by Shambhu Roy Breakdown of academic impact, for papers by Camille Géniès Breakdown of academic impact, for papers by Albrecht Poth Breakdown of academic impact, for papers by Özge Cemiloğlu Ülker Breakdown of academic impact, for papers by Joanna Klapacz Breakdown of academic impact, for papers by Shinobu Wakuri Breakdown of academic impact, for papers by Jian‐Dong Duan
Rankless by CCL
2026